Taishu Wang

820 total citations
15 papers, 608 citations indexed

About

Taishu Wang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Taishu Wang has authored 15 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Taishu Wang's work include Ubiquitin and proteasome pathways (7 papers), Glycosylation and Glycoproteins Research (3 papers) and Autophagy in Disease and Therapy (3 papers). Taishu Wang is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Glycosylation and Glycoproteins Research (3 papers) and Autophagy in Disease and Therapy (3 papers). Taishu Wang collaborates with scholars based in China, Egypt and United States. Taishu Wang's co-authors include Han Liu, Jinrui Zhang, Yingqiu Zhang, Shuyan Liu, Yueguang Wu, Fang Liu, Duchuang Wang, Yulin Shi, Shanshan Wang and Yang Zhang and has published in prestigious journals such as Cell Death and Differentiation, Archives of Biochemistry and Biophysics and Cancer Letters.

In The Last Decade

Taishu Wang

15 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taishu Wang China 10 427 166 115 90 59 15 608
Minsoo Koh South Korea 13 391 0.9× 178 1.1× 109 0.9× 128 1.4× 56 0.9× 17 717
Sanjib Chaudhary United States 15 373 0.9× 223 1.3× 117 1.0× 97 1.1× 84 1.4× 28 668
Yingqiu Zhang China 15 487 1.1× 225 1.4× 139 1.2× 119 1.3× 78 1.3× 31 772
Bruno Ricardo Barreto Pires Brazil 10 308 0.7× 210 1.3× 176 1.5× 110 1.2× 51 0.9× 27 627
Shelley J. Edmunds New Zealand 13 486 1.1× 176 1.1× 216 1.9× 67 0.7× 60 1.0× 15 759
Begoña Cánovas Spain 6 432 1.0× 125 0.8× 94 0.8× 76 0.8× 41 0.7× 8 677
Rongrui Liang China 11 267 0.6× 153 0.9× 112 1.0× 90 1.0× 67 1.1× 23 520
Constantin Busuioc Romania 5 430 1.0× 179 1.1× 135 1.2× 62 0.7× 87 1.5× 13 722
Shudong Zhu China 12 367 0.9× 112 0.7× 110 1.0× 76 0.8× 65 1.1× 24 539
Elena Aréchaga-Ocampo Mexico 17 506 1.2× 148 0.9× 247 2.1× 62 0.7× 63 1.1× 35 747

Countries citing papers authored by Taishu Wang

Since Specialization
Citations

This map shows the geographic impact of Taishu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taishu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taishu Wang more than expected).

Fields of papers citing papers by Taishu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taishu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taishu Wang. The network helps show where Taishu Wang may publish in the future.

Co-authorship network of co-authors of Taishu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Taishu Wang. A scholar is included among the top collaborators of Taishu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taishu Wang. Taishu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Wang, Shanshan, Taishu Wang, Lanjing Zhang, et al.. (2023). The deubiquitylating enzyme USP35 restricts regulated cell death to promote survival of renal clear cell carcinoma. Cell Death and Differentiation. 30(7). 1757–1770. 9 indexed citations
2.
Sun, Qianhui, Jinrui Zhang, Xiaoxi Li, et al.. (2022). The ubiquitin-specific protease 8 antagonizes melatonin-induced endocytic degradation of MT1 receptor to promote lung adenocarcinoma growth. Journal of Advanced Research. 41. 1–12. 10 indexed citations
3.
Wang, Shanshan, Taishu Wang, Fang Liu, et al.. (2022). Proteasomal deubiquitylase activity enhances cell surface recycling of the epidermal growth factor receptor in non-small cell lung cancer. Cellular Oncology. 45(5). 951–965. 7 indexed citations
4.
Lv, Yuesheng, Wenjing Zhang, Jinyao Zhao, et al.. (2021). SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer. Signal Transduction and Targeted Therapy. 6(1). 108–108. 80 indexed citations
5.
Liu, Shuyan, Taishu Wang, Yulin Shi, et al.. (2021). USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis. Cell Death and Differentiation. 28(8). 2482–2498. 43 indexed citations
6.
Zhang, Jinrui, Shuyan Liu, Qiong Li, et al.. (2020). The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer. Cell Death and Differentiation. 27(9). 2710–2725. 38 indexed citations
7.
Wu, Yueguang, Yingqiu Zhang, Duchuang Wang, et al.. (2020). USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress. Cell Death and Disease. 11(9). 796–796. 30 indexed citations
8.
Wang, Shanshan, Jinrui Zhang, Taishu Wang, et al.. (2019). Endocytic degradation of ErbB2 mediates the effectiveness of neratinib in the suppression of ErbB2-positive ovarian cancer. The International Journal of Biochemistry & Cell Biology. 117. 105640–105640. 3 indexed citations
9.
Zaky, Mohamed Y., Xiuxiu Liu, Taishu Wang, et al.. (2019). Dynasore potentiates c-Met inhibitors against hepatocellular carcinoma through destabilizing c-Met. Archives of Biochemistry and Biophysics. 680. 108239–108239. 7 indexed citations
10.
Zhang, Jinrui, Qiong Li, Yueguang Wu, et al.. (2019). Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer. Cell Communication and Signaling. 17(1). 15–15. 96 indexed citations
11.
Wang, Taishu, Jinrui Zhang, Shanshan Wang, et al.. (2018). The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms. Cell Communication and Signaling. 16(1). 40–40. 19 indexed citations
12.
Zhang, Yang, Kang Tian, Xi Chen, et al.. (2018). Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects. Journal of Experimental & Clinical Cancer Research. 37(1). 261–261. 147 indexed citations
13.
Wang, Taishu, Duchuang Wang, Jinrui Zhang, et al.. (2018). Dynasore-induced potent ubiquitylation of the exon 19 deletion mutant of epidermal growth factor receptor suppresses cell growth and migration in non-small cell lung cancer. The International Journal of Biochemistry & Cell Biology. 105. 1–12. 6 indexed citations
14.
Wang, Mengying, Yayun Zhang, Taishu Wang, et al.. (2017). The USP7 Inhibitor P5091 Induces Cell Death in Ovarian Cancers with Different P53 Status. Cellular Physiology and Biochemistry. 43(5). 1755–1766. 50 indexed citations
15.
Zhang, Yingqiu, Jinrui Zhang, Congcong Liu, et al.. (2016). Neratinib induces ErbB2 ubiquitylation and endocytic degradation via HSP90 dissociation in breast cancer cells. Cancer Letters. 382(2). 176–185. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026